{"id":4231,"date":"2021-09-30T22:02:48","date_gmt":"2021-09-30T22:02:48","guid":{"rendered":"https:\/\/finascope.fr\/?p=4231"},"modified":"2021-10-01T06:51:10","modified_gmt":"2021-10-01T06:51:10","slug":"icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante","status":"publish","type":"post","link":"https:\/\/finascope.fr\/english\/operations\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\/","title":{"rendered":"Icade postpones the IPO of its subsidiary Icade Sant\u00e9"},"content":{"rendered":"

Market conditions did not allow us to... <\/p>\n

\n
\n

<\/rect><\/path><\/svg>Purchase Required<\/h2>\n
\n

This content requires that you purchase additional access. The price is \u20ac20.00.<\/p>\n

Click Here to Check Out<\/a><\/p>\n<\/div>\n

Already a member? Log in here<\/a><\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

Market conditions did not allow us to... <\/p>\n

<\/rect><\/path><\/svg>Purchase Required<\/h2>

This content requires that you purchase additional access. The price is \u20ac20.00.<\/p>

Click Here to Check Out<\/a><\/p><\/div>

Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":11,"featured_media":4233,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"pmpro_default_level":"","footnotes":""},"categories":[4,3],"tags":[],"class_list":["post-4231","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-operations","category-tendances","pmpro-level-required","pmpro-level-8","pmpro-level-10","pmpro-level-11","pmpro-level-12","pmpro-level-14","pmpro-no-access","entry","has-media"],"yoast_head":"\nIcade reporte l\u2019introduction en Bourse de sa filiale Icade Sant\u00e9 - Finascope<\/title>\n<meta name=\"description\" content=\"Les conditions de march\u00e9 n\u2019ont pas permis de boucler une op\u00e9ration pourtant bien avanc\u00e9e. Afyren et Entech ont toutefois r\u00e9ussi leur entr\u00e9e sur Euronext cette semaine. Tout au bout du parcours, Icade Sant\u00e9 a d\u00fb suspendre son projet d\u2019introduction en Bourse. Dans l\u2019apr\u00e8s-midi, des informations \u00e9manant des teneurs de livre avaient pourtant laiss\u00e9 entendre que l\u2019op\u00e9ration allait \u00eatre boucl\u00e9e \u00e0 115 euros l\u2019action, soit sur la borne basse de la fourchette de cotation annonc\u00e9e, de 115 \u00e0 135 euros.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/finascope.fr\/english\/en\/operations\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Icade reporte l\u2019introduction en Bourse de sa filiale Icade Sant\u00e9 - Finascope\" \/>\n<meta property=\"og:description\" content=\"Les conditions de march\u00e9 n\u2019ont pas permis de boucler une op\u00e9ration pourtant bien avanc\u00e9e. Afyren et Entech ont toutefois r\u00e9ussi leur entr\u00e9e sur Euronext cette semaine. Tout au bout du parcours, Icade Sant\u00e9 a d\u00fb suspendre son projet d\u2019introduction en Bourse. Dans l\u2019apr\u00e8s-midi, des informations \u00e9manant des teneurs de livre avaient pourtant laiss\u00e9 entendre que l\u2019op\u00e9ration allait \u00eatre boucl\u00e9e \u00e0 115 euros l\u2019action, soit sur la borne basse de la fourchette de cotation annonc\u00e9e, de 115 \u00e0 135 euros.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/finascope.fr\/english\/en\/operations\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\/\" \/>\n<meta property=\"og:site_name\" content=\"Finascope\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-30T22:02:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-01T06:51:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/finascope.fr\/wp-content\/uploads\/2021\/09\/Icade-sante.png\" \/>\n\t<meta property=\"og:image:width\" content=\"928\" \/>\n\t<meta property=\"og:image:height\" content=\"583\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Nicolas Raulot\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nicolas Raulot\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/finascope.fr\\\/en\\\/operations\\\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/en\\\/operations\\\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\\\/\"},\"author\":{\"name\":\"Nicolas Raulot\",\"@id\":\"https:\\\/\\\/finascope.fr\\\/#\\\/schema\\\/person\\\/7225790e8225e73e673f4460c957a3fe\"},\"headline\":\"Icade reporte l\u2019introduction en Bourse de sa filiale Icade Sant\u00e9\",\"datePublished\":\"2021-09-30T22:02:48+00:00\",\"dateModified\":\"2021-10-01T06:51:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/en\\\/operations\\\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\\\/\"},\"wordCount\":860,\"publisher\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/en\\\/operations\\\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/finascope.fr\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Icade-sante.png\",\"articleSection\":[\"Op\u00e9ration\",\"Tendance\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/finascope.fr\\\/en\\\/operations\\\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\\\/\",\"url\":\"https:\\\/\\\/finascope.fr\\\/en\\\/operations\\\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\\\/\",\"name\":\"Icade reporte l\u2019introduction en Bourse de sa filiale Icade Sant\u00e9 - Finascope\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/en\\\/operations\\\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/en\\\/operations\\\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/finascope.fr\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Icade-sante.png\",\"datePublished\":\"2021-09-30T22:02:48+00:00\",\"dateModified\":\"2021-10-01T06:51:10+00:00\",\"description\":\"Les conditions de march\u00e9 n\u2019ont pas permis de boucler une op\u00e9ration pourtant bien avanc\u00e9e. Afyren et Entech ont toutefois r\u00e9ussi leur entr\u00e9e sur Euronext cette semaine. Tout au bout du parcours, Icade Sant\u00e9 a d\u00fb suspendre son projet d\u2019introduction en Bourse. Dans l\u2019apr\u00e8s-midi, des informations \u00e9manant des teneurs de livre avaient pourtant laiss\u00e9 entendre que l\u2019op\u00e9ration allait \u00eatre boucl\u00e9e \u00e0 115 euros l\u2019action, soit sur la borne basse de la fourchette de cotation annonc\u00e9e, de 115 \u00e0 135 euros.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/en\\\/operations\\\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/finascope.fr\\\/en\\\/operations\\\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/finascope.fr\\\/en\\\/operations\\\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\\\/#primaryimage\",\"url\":\"https:\\\/\\\/finascope.fr\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Icade-sante.png\",\"contentUrl\":\"https:\\\/\\\/finascope.fr\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Icade-sante.png\",\"width\":928,\"height\":583,\"caption\":\"Icade Sant\u00e9 est sp\u00e9cialis\u00e9e dans les r\u00e9sidences de services pour personnes \u00e2g\u00e9es et les cliniques priv\u00e9es.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/finascope.fr\\\/en\\\/operations\\\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/finascope.fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Icade reporte l\u2019introduction en Bourse de sa filiale Icade Sant\u00e9\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/finascope.fr\\\/#website\",\"url\":\"https:\\\/\\\/finascope.fr\\\/\",\"name\":\"Finascope\",\"description\":\"L'info des march\u00e9s et des investissements \u00e0 Paris\",\"publisher\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/finascope.fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/finascope.fr\\\/#organization\",\"name\":\"Finascope\",\"url\":\"https:\\\/\\\/finascope.fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/finascope.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/finascope.fr\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/Logo-Finascope-500.jpeg\",\"contentUrl\":\"https:\\\/\\\/finascope.fr\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/Logo-Finascope-500.jpeg\",\"width\":500,\"height\":128,\"caption\":\"Finascope\"},\"image\":{\"@id\":\"https:\\\/\\\/finascope.fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/finascope.fr\\\/#\\\/schema\\\/person\\\/7225790e8225e73e673f4460c957a3fe\",\"name\":\"Nicolas Raulot\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0b28951d3063a3c3439174ac769734c4f14a35a107e4e77fb6b5023ef041a0ab?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0b28951d3063a3c3439174ac769734c4f14a35a107e4e77fb6b5023ef041a0ab?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0b28951d3063a3c3439174ac769734c4f14a35a107e4e77fb6b5023ef041a0ab?s=96&d=mm&r=g\",\"caption\":\"Nicolas Raulot\"},\"url\":\"https:\\\/\\\/finascope.fr\\\/english\\\/author\\\/scofi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Icade postpones the IPO of its subsidiary Icade Sant\u00e9 - Finascope","description":"Market conditions made it impossible to complete a deal that was well advanced. However, Afyren and Entech successfully floated on Euronext this week. At the very end of the process, Icade Sant\u00e9 had to suspend its planned IPO. In the afternoon, information from the bookrunners had suggested that the deal would be completed at \u20ac115 per share, at the lower end of the announced price range of \u20ac115 to \u20ac135.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/finascope.fr\/english\/en\/operations\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\/","og_locale":"en_GB","og_type":"article","og_title":"Icade reporte l\u2019introduction en Bourse de sa filiale Icade Sant\u00e9 - Finascope","og_description":"Les conditions de march\u00e9 n\u2019ont pas permis de boucler une op\u00e9ration pourtant bien avanc\u00e9e. Afyren et Entech ont toutefois r\u00e9ussi leur entr\u00e9e sur Euronext cette semaine. Tout au bout du parcours, Icade Sant\u00e9 a d\u00fb suspendre son projet d\u2019introduction en Bourse. Dans l\u2019apr\u00e8s-midi, des informations \u00e9manant des teneurs de livre avaient pourtant laiss\u00e9 entendre que l\u2019op\u00e9ration allait \u00eatre boucl\u00e9e \u00e0 115 euros l\u2019action, soit sur la borne basse de la fourchette de cotation annonc\u00e9e, de 115 \u00e0 135 euros.","og_url":"https:\/\/finascope.fr\/english\/en\/operations\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\/","og_site_name":"Finascope","article_published_time":"2021-09-30T22:02:48+00:00","article_modified_time":"2021-10-01T06:51:10+00:00","og_image":[{"width":928,"height":583,"url":"https:\/\/finascope.fr\/wp-content\/uploads\/2021\/09\/Icade-sante.png","type":"image\/png"}],"author":"Nicolas Raulot","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Nicolas Raulot","Estimated reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/finascope.fr\/en\/operations\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\/#article","isPartOf":{"@id":"https:\/\/finascope.fr\/en\/operations\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\/"},"author":{"name":"Nicolas Raulot","@id":"https:\/\/finascope.fr\/#\/schema\/person\/7225790e8225e73e673f4460c957a3fe"},"headline":"Icade reporte l\u2019introduction en Bourse de sa filiale Icade Sant\u00e9","datePublished":"2021-09-30T22:02:48+00:00","dateModified":"2021-10-01T06:51:10+00:00","mainEntityOfPage":{"@id":"https:\/\/finascope.fr\/en\/operations\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\/"},"wordCount":860,"publisher":{"@id":"https:\/\/finascope.fr\/#organization"},"image":{"@id":"https:\/\/finascope.fr\/en\/operations\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\/#primaryimage"},"thumbnailUrl":"https:\/\/finascope.fr\/wp-content\/uploads\/2021\/09\/Icade-sante.png","articleSection":["Op\u00e9ration","Tendance"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/finascope.fr\/en\/operations\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\/","url":"https:\/\/finascope.fr\/en\/operations\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\/","name":"Icade postpones the IPO of its subsidiary Icade Sant\u00e9 - Finascope","isPartOf":{"@id":"https:\/\/finascope.fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/finascope.fr\/en\/operations\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\/#primaryimage"},"image":{"@id":"https:\/\/finascope.fr\/en\/operations\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\/#primaryimage"},"thumbnailUrl":"https:\/\/finascope.fr\/wp-content\/uploads\/2021\/09\/Icade-sante.png","datePublished":"2021-09-30T22:02:48+00:00","dateModified":"2021-10-01T06:51:10+00:00","description":"Market conditions made it impossible to complete a deal that was well advanced. However, Afyren and Entech successfully floated on Euronext this week. At the very end of the process, Icade Sant\u00e9 had to suspend its planned IPO. In the afternoon, information from the bookrunners had suggested that the deal would be completed at \u20ac115 per share, at the lower end of the announced price range of \u20ac115 to \u20ac135.","breadcrumb":{"@id":"https:\/\/finascope.fr\/en\/operations\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/finascope.fr\/en\/operations\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/finascope.fr\/en\/operations\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\/#primaryimage","url":"https:\/\/finascope.fr\/wp-content\/uploads\/2021\/09\/Icade-sante.png","contentUrl":"https:\/\/finascope.fr\/wp-content\/uploads\/2021\/09\/Icade-sante.png","width":928,"height":583,"caption":"Icade Sant\u00e9 est sp\u00e9cialis\u00e9e dans les r\u00e9sidences de services pour personnes \u00e2g\u00e9es et les cliniques priv\u00e9es."},{"@type":"BreadcrumbList","@id":"https:\/\/finascope.fr\/en\/operations\/icade-reporte-lintroduction-en-bourse-de-sa-filiale-icade-sante\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/finascope.fr\/"},{"@type":"ListItem","position":2,"name":"Icade reporte l\u2019introduction en Bourse de sa filiale Icade Sant\u00e9"}]},{"@type":"WebSite","@id":"https:\/\/finascope.fr\/#website","url":"https:\/\/finascope.fr\/","name":"Finascope","description":"Market and investment news from Paris","publisher":{"@id":"https:\/\/finascope.fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/finascope.fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/finascope.fr\/#organization","name":"Finascope","url":"https:\/\/finascope.fr\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/finascope.fr\/#\/schema\/logo\/image\/","url":"https:\/\/finascope.fr\/wp-content\/uploads\/2021\/05\/Logo-Finascope-500.jpeg","contentUrl":"https:\/\/finascope.fr\/wp-content\/uploads\/2021\/05\/Logo-Finascope-500.jpeg","width":500,"height":128,"caption":"Finascope"},"image":{"@id":"https:\/\/finascope.fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/finascope.fr\/#\/schema\/person\/7225790e8225e73e673f4460c957a3fe","name":"Nicolas Raulot","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/0b28951d3063a3c3439174ac769734c4f14a35a107e4e77fb6b5023ef041a0ab?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0b28951d3063a3c3439174ac769734c4f14a35a107e4e77fb6b5023ef041a0ab?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0b28951d3063a3c3439174ac769734c4f14a35a107e4e77fb6b5023ef041a0ab?s=96&d=mm&r=g","caption":"Nicolas Raulot"},"url":"https:\/\/finascope.fr\/english\/author\/scofi\/"}]}},"_links":{"self":[{"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/posts\/4231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/comments?post=4231"}],"version-history":[{"count":2,"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/posts\/4231\/revisions"}],"predecessor-version":[{"id":4247,"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/posts\/4231\/revisions\/4247"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/media\/4233"}],"wp:attachment":[{"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/media?parent=4231"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/categories?post=4231"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finascope.fr\/english\/wp-json\/wp\/v2\/tags?post=4231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}